Abstracts / Abstrakts
- 1) Belz GG. Studies on pharmacokinetics of procillaridin-4'-methylether
in man. Naunyn-Schmiedeberg's Arch Pharmacol 1974;282:R 7.
- 2) Belz GG, Brech WJ. Blood levels and rates of
excretion of proscillaridin in normal probands and patients with
renal failure. IRCS 1974;2:1019.
- 3) Belz GG, Stauch R, Nübling H, Rietbrock N. Pharmacokinetics
and metabolism of repetitive methylproscillaridin administration
in man. Naunyn-Schmiedeberg's Arch Pharmacol 1974;285:R 4.
- 4) Lang D, Hofstetter R, Belz GG, von Bernuth G. Digoxinspiegel
und Halbwertzeit im Serum Frühgeborener und Neugeborener. Herz/Kreislauf
1975;7:214.
- 5) Nübling H, Belz GG, Bader H. The influence
of digoxin metabolites on 86Rb-uptake of human erythrocytes. Naunyn-Schmiedeberg's
Arch Pharmacol 1975;287:R 41.
- 6) Belz GG, Erbel R, Heinz N. Biological activity
of polar and nonpolar digoxin - and digitoxin - metabolites. Naunyn-Schmiedeberg's
Arch Pharmacol 1977;297:R 27.
- 7) Joubert P, Belz GG. Die Verband Tussen die
Effek van Digitalis op die EKG en Inotropie. South Afr J Sci 1979;75:321-322.
- 8) Aust PE, Belz GG, Appel E, Palm D. Kardiovaskuläre
Wirkungen von Amezinium metilsulfat (AM). Z Kardiol 1980;69:716.
- 9) Belz GG, Doering W, Aust PE, Heinz M, Belz G. Quinidine-digoxin-interaction:
A crossover double-blind study on cardiac efficacy of increasing
serum digoxin concentrations. Circulation 1981;64:IV-135.
- 10) Belz GG, Doering W, Munkes R, Aust PE, Belz G. Effects
of various calcium-antagonists on blood level and renal clearance
of digoxin. Circulation 1981;64:IV-24.
- 11) Doering W, Belz GG, Aust PE, König E. Quinidine
(Q)-digoxin (D) interaction: Are the increasing serum digoxin concentrations
(SDC) of cardiac efficacy? Eur Heart J 1981;2(Suppl.A):117.
- 12) Doering W, Belz GG, Aust PE, Rieger G, König E. Chinidin-Digoxin-Interaktion
(C-D-I): Sind die hohen Digoxinkonzentrationen im Serum (DKS) kardial
wirksam?
Z Kardiol 1981;70:310.
- 13) Belz GG, Matthews J, Doering W, Belz G. Digoxin
antiarrhythmics: Pharmacodynamic and pharmacokinetic studies
with quinidine, propafenon, and verapamil. Clin Pharmacol Ther 1982;31:202-203.
- 14) Belz GG, Alken RG, Haegele KD, Meinicke T, Belz G,
Schechter PJ.Pharmacodynamic and pharmacokinetic
studies on MDL 17.043, a new cardiotonic agent. Clin Pharmacol
Ther 1983;33:202.
> 1 2 3 4 5 6 7 8